Tissue Diagnostics (TDx) Market is estimated to be US$ 13814.7 million by 2030 with a CAGR of 9.30% during the forecast period

Download Sample

Published Date: June 2023

Tissue Diagnostics (TDx) Market accounted for US$ 5699.59 million in 2020 and is estimated to be US$ 13814.7 million by 2030 and is anticipated to register a CAGR of 9.30%. Tissue diagnostics are very accurate, low-cost, and can be done using a variety of procedures, including core and open biopsy. These diagnoses are now performed using modern technologies such as immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special labelling. The overall share of the geriatric population is currently growing steadily over the world due to decreased fertility rates and higher life expectancy. Because older persons are more susceptible to chronic diseases and hence require frequent check-ups and diagnoses, this is a critical element contributing to market growth. Aside from that, changes in eating habits, increased alcohol consumption, and decreased physical activity have all contributed to an increase in the prevalence of a variety of lifestyle diseases.

The report " Global Tissue Diagnostics (TDx) Market, By Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), By Technology (ISH, IHC, Special Staining), By Disease (Breast Cancer, NSCLC, Lymphoma), By End User (Hospitals, Research Laboratories) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’

Key Highlights:

The Roche VENTANA PD-L1 (SP142) Assay was introduced in CE (Conformité Européenne) markets in 2019.
Hologic's ThinPrep Genesis Processor obtained CE certification in 2019.
Roche and GE Healthcare announced a collaboration in 2019 to build an integrated digital diagnostics platform to improve oncology and critical care therapy.

Analyst View:

Tissue-based diagnostic tests play an important part in current medical practise, and they are used to diagnose a variety of disorders using a variety of tools and consumables. Tissue diagnostic goods, such as tools and consumables, must meet stringent quality standards in order to be used in tissue-based diagnostic procedures. Furthermore, the tissue diagnostics market is highly consolidated, with only a few significant competitors controlling the whole market. New entrants to this sector face significant entry hurdles due to stringent regulatory requirements and a high degree of consolidation.

Browse 60 market data tables and 35 figures* through 140 slides and in-depth TOC on “*Global Tissue Diagnostics (TDx) Market, By Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), By Technology (ISH, IHC, Special Staining), By Disease (Breast Cancer, NSCLC, Lymphoma), By End User (Hospitals, Research Laboratories) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Market Insights from the report:

Global Tissue Diagnostics (TDx) Market accounted for US$ 5699.59 million in 2020 and is estimated to be US$ 13814.7 million by 2030 and is anticipated to register a CAGR of 9.30%. The Global Tissue Diagnostics (TDx) Market is segmented based on technology, product, disease, end-user and region.

Based on Technology, Global Tissue Diagnostics (TDx) Market is segmented into ISH, IHC, Special Staining.
Based on Product, Global Tissue Diagnostics (TDx) Market is segmented into Antibodies, Kits, Slide Staining System, Tissue Processing System.
Based on Disease, Global Tissue Diagnostics (TDx) Market is segmented into Breast Cancer, NSCLC, Lymphoma.
Based on End-User, Global Tissue Diagnostics (TDx) Market is segmented into Hospitals, Research Laboratories.
By Region, the Global Tissue Diagnostics (TDx) Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Global Tissue Diagnostics (TDx) Market:

The prominent players operating in the Global Tissue Diagnostics (TDx) Market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), ABCAM (UK), Merck KGAA (Germany), BD (US), Hologic (US), Bio Rad (US), Biomeriux (France), Sakura Fientek Japan (Japan), BioSB (US), Biogenex (US), Cell Signaling Technology (US), Histoline Laboratories (Italy), Slee Medical GMBH (Germany), Amos Scientific PTY Ltd (Australia), Jinhua Yidi Medical Appliance Co.Ltd (China), Medite GMBH (Germany), Cellpath Ltd(UK), and Dipath S.P.A. (Italy).

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period